Your browser doesn't support javascript.
The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study.
Egan, Pamela C; Jani, Chinmay; Singh, Harpreet; Mishra, Sanjay; Warner, Jeremy L.
  • Egan PC; Lifespan Cancer Institute, Providence, Rhode Island.
  • Jani C; Brown University, Providence, Rhode Island.
  • Singh H; Mount Auburn Hospital, Cambridge, Massachusetts.
  • Mishra S; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Warner JL; Lifespan Cancer Institute, Providence, Rhode Island.
Cancer Epidemiol Biomarkers Prev ; 32(1): 3-5, 2023 01 09.
Article in English | MEDLINE | ID: covidwho-2194258
ABSTRACT
Multiple prior studies have shown an increased risk of severe disease and death from SARS-CoV-2 infection in patients with cancer. Nolan and colleagues conducted a multi-institution, electronic health record (EHR)-based study of adults hospitalized with COVID-19 delineating the difference in outcomes when stratified by current versus former cancer diagnosis and found that only a current diagnosis appears to confer an increased risk of severe COVID-19 and death.We review these findings in the context of other studies examining outcomes for individuals with cancer diagnoses and COVID-19. We also address questions raised by this type of study about the significant challenges of EHR-based studies and discuss potential avenues for future research in this arena. See related article by Nolan et al., p. 12.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study / Prognostic study Limits: Adult / Humans Country/Region as subject: North America Language: English Journal: Cancer Epidemiol Biomarkers Prev Journal subject: Biochemistry / Epidemiology / Neoplasms Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study / Prognostic study Limits: Adult / Humans Country/Region as subject: North America Language: English Journal: Cancer Epidemiol Biomarkers Prev Journal subject: Biochemistry / Epidemiology / Neoplasms Year: 2023 Document Type: Article